🇺🇸 FDA
Patent

US 9511075

Targeting NCCA-ATP channel for organ protection following ischemic episode

granted A61KA61K31/427A61K31/565

Quick answer

US patent 9511075 (Targeting NCCA-ATP channel for organ protection following ischemic episode) held by The United States of America as Represented by the Dept. of Veterans Affairs expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Dept. of Veterans Affairs
Grant date
Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/427, A61K31/565, A61K31/57, A61K31/64